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Abstract
Approximately one-third of the world’s population suffers from chronic helminth infections with no effective vaccines
currently available. Antibodies and alternatively activated macrophages (AAM) form crucial components of protective
immunity against challenge infections with intestinal helminths. However, the mechanisms by which antibodies target
these large multi-cellular parasites remain obscure. Alternative activation of macrophages during helminth infection has
been linked to signaling through the IL-4 receptor alpha chain (IL-4Ra), but the potential effects of antibodies on
macrophage differentiation have not been explored. We demonstrate that helminth-specific antibodies induce the rapid
trapping of tissue migrating helminth larvae and prevent tissue necrosis following challenge infection with the natural
murine parasite Heligmosomoides polygyrus bakeri (Hp). Mice lacking antibodies (JH
2/2) or activating Fc receptors (FcRc2/2)
harbored highly motile larvae, developed extensive tissue damage and accumulated less Arginase-1 expressing
macrophages around the larvae. Moreover, Hp-specific antibodies induced FcRc- and complement-dependent adherence
of macrophages to larvae in vitro, resulting in complete larval immobilization. Antibodies together with helminth larvae
reprogrammed macrophages to express wound-healing associated genes, including Arginase-1, and the Arginase-1 product
L-ornithine directly impaired larval motility. Antibody-induced expression of Arginase-1 in vitro and in vivo occurred
independently of IL-4Ra signaling. In summary, we present a novel IL-4Ra-independent mechanism of alternative
macrophage activation that is antibody-dependent and which both mediates anti-helminth immunity and prevents tissue
disruption caused by migrating larvae.
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Introduction
Intestinal helminths present a major global health burden,
particularly in developing countries. Patients that are infected with
nematodes such as Ascaris lumbricoides, Trichuris trichuria or Necator
americanus often develop severe pathology and impaired respon-
siveness to vaccines [1] [2] [3] [4]. Approximately 2 billion people
are infected with intestinal nematodes, with the most severe
infections often found within school children [5] [6]. Although
such infections can be treated by chemotherapy, worm burdens
typically reach pretreatment levels within 6 months [7] [5].
Moreover, drug resistant helminths present a pressing problem for
livestock [8], raising concerns about the long-term validity of
chemotherapy amongst human populations [9] [10] [11] [6] [12]
[13]. Unfortunately, no efficacious vaccines against intestinal
nematodes are available to date, making an improved under-
standing of host immunity imperative.
Macrophages are highly plastic immune cells that can fulfill
diverse tasks in immunity, metabolism and wound-healing
depending on their tissue location and inflammatory context
[14]. In the context of bacterial infection, the activation of
classically activated macrophages by serum components such as
antibodies and complement can enhance the phagocytosis and
killing of bacterial or fungal pathogens [15]. By contrast, type 2
immune responses associated with helminth infection and allergies
are characterized by a predominance of alternatively activated
macrophages (AAM) that appear to play a role in anti-helminth
immunity and wound repair through ill-defined mechanisms [16]
[17].
Infection with the natural murine parasite Heligmosomoides
polygyrus bakeri (Hp) is a common model used to study immunity
against helminth infection [18]. Following primary (1u) infection
with Hp, C57BL/6 mice develop a chronic infection [19]. In
contrast, Hp fails to establish chronicity after challenge infection,
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largely due to the rapid development of a protective TH2 type
granuloma around the tissue invasive larvae [20] [21] [22]. The
highly concentrated accumulation of Arginase-1 (Arg1) expressing
alternatively activated macrophages in inflammatory lesions is a
hallmark of type 2 responses associated with allergy or helminth
infection [23] [24] [25]. Recent reports have demonstrated an
important role for type 2 cytokine driven alternative activation of
macrophages in protective immunity against intestinal helminth
infection [16] [26] [27]. Previous work [28] [29], including a study
from our own group [30], additionally identified helminth-specific
antibodies as essential components of immunity against Hp.
Passive transfer of IgG or immune serum could also confer
resistance to Hp, Ascaris suum and Strongyloides ratti [31] [32] [33],
and antibody production has been found to correlate with
protection in human helminth infection [34] [35] [36]. Whilst
antibodies contribute to protective immunity against Hp and other
nematodes such as Trichuris muris or whipworms such as Trichinella
spiralis, which cause chronic infections [37] [38], they are not
required for rapid expulsion of the hookworm Nippostrongylus
braziliensis [29]. However, the mechanism of antibody-mediated
immunity against intestinal helminths has remained obscure.
In the current study we investigated the mechanisms of antibody-
mediated immunity following challenge Hp infection and demon-
strate that antibodies function to trap helminth larvae and to
prevent parasite-induced tissue damage. Using newly developed
tools for image analysis, we show that antibody-activated macro-
phages upregulate Arg1 and immobilize infective and tissue
dwelling larvae. Intriguingly, the reprogramming of macrophages
by helminth-specific antibodies did not require IL-4Ra signaling,
indicating that antibody activation of macrophages during helminth
infection represents a novel pathway of alternative macrophage
differentiation. In summary we have shown that antibodies in the
presence of helminth antigens can elicit a novel subtype of IL-4Ra
independent alternatively activated macrophages, which we refer to
as helminth-antibody activated macrophages (HAAM).
Results
Mice deficient in antibodies or activating antibody
receptors exhibit impaired early immunity to H. polygyrus
bakeri challenge infections
Our previous work on antibody mediated protective immunity
against Hp has largely been focused on late time points (day 14–20)
after challenge infection, when adult worms can be found in the
lumen of the small intestine [30]. However, protective immunity is
initiated as early as day four of challenge Hp infection [16] [29],
when larvae have first invaded the intestinal mucosa. Thus, in
order to investigate a potential early effect of antibodies in the
memory response to Hp, we analysed the numbers of larvae that
had invaded the small intestine of infected antibody-deficient
JH
2/2 mice (for accession numbers of gene name abbreviations
used in this manuscript see Table 1). JH
2/2 mice carry a deletion
of the joining fragment of the immunoglobulin heavy chain locus
and are devoid of mature B-cells and antibodies [39]. As shown in
Fig. 1A, and in line with previous work [29], JH
2/2 harbored
significantly higher numbers of L4 on day 4 after challenge
infection. As previous work indicated a small but significant
contribution of cellular activation via activating Fc receptors on
the numbers of adult worms [30], we additionally assessed
numbers of larvae in challenge infected mice lacking activating
Fc receptors (FcRc2/2). Interestingly, these mice also exhibited
clearly increased larval burdens (Fig. 1A).
Antibody and FcRgamma-deficient mice exhibit larger
granulomas, a tendency to develop necrosis and greater
larval motility
In addition to the increased numbers of larvae, we observed that
JH
2/2 and FcRc2/2 mice exhibited larger granulomas at day 4
post challenge Hp infection. Assessment of hematoxylin and eosin
(H&E) stained tissue sections revealed that granulomas in all sets of
mice were characterized by epitheloid macrophages and eosino-
phils and often contained cuticle remains or intact larvae (Fig. 1B).
Quantification of the inflamed area for lesions containing intact
larvae (Fig. 1B, left column), or for lesions without intact larvae
(Fig. 1B, right column), showed that JH
2/2 and FcRc2/2 mice
had indeed developed more extensive granulomas around intact
larvae (Fig. 1C) and larger ‘‘cysts’’ without visible larvae (Fig. 1D).
Finally, pathological scoring of H&E stained granuloma sections
showed an increased tendency to develop necrosis in both JH
2/2
and FcRc2/2 mice (Fig. 1E).
We rationalized that a failure to efficiently trap larvae in the
granuloma might contribute to the observed increase in tissue
necrosis. As the assessment of larval numbers by a modified
Baermann apparatus only gives an indirect measure of larval motility
[16], we quantified in-tissue motility directly by microscopy. Our
analysis of time-lapse movies (Text S1, Fig. S1) showed that in-tissue
motility was increased in the absence of antibodies or activating
antibody receptors (Movie S1, Fig. 1F). During our analysis, we also
noted pronounced differences in the size of larvae between wildtype,
FcRc2/2 and JH
2/2 mice (Fig. 1G). We therefore calculated the
difference in the larval position after 60s relative to the total larval
area. In FcRc2/2 and JH
2/2 mice, the movement of the larvae was
still observed to be greater than that seen for wildtype mice even
when the movement was normalized to larval size (Fig. 1H).
Cellular compositions of granulomas are similar in
wildtype and antibody-deficient mice
Due to the apparent involvement of cellular activation via Fc
receptors in antibody-mediated protection against Hp (Fig. 1) we
Author Summary
Intestinal helminths present a pressing problem in
developing countries with approximately 2 billion people
suffering from chronic infection. To date no successful
vaccines are available and a detailed mechanistic under-
standing of anti-helminth immunity is urgently needed to
improve strategies for prevention and therapy. Antibodies
form a crucial component of protective immunity against
challenge infections with intestinal helminths. However,
the exact mechanisms by which antibodies target these
large multi-cellular parasites have remained obscure. We
now demonstrate that helminth-specific antibodies induce
the rapid trapping of tissue migrating helminth larvae by
activating phagocytes. In the absence of antibodies or
their receptors, helminth-infected mice developed exten-
sive tissue damage, revealing a novel role for antibodies in
limiting parasite-caused tissue disruption. Furthermore,
helminth-specific antibodies reprogrammed macrophages
to express wound-healing factors such as the arginine-
metabolizing enzyme Arginase-1. Interestingly, the Argi-
nase-1 product L-ornithine directly impaired the motility of
helminth larvae. In summary, our study provides detailed
mechanistic insights into how antibodies can modulate
phagocyte function to provide protection against a large
multi-cellular parasite. Our findings suggest that novel
anti-helminth vaccines should target the larval surface and
activate wound-healing macrophages to provide rapid
protection against tissue-disruptive larvae.
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performed a flow cytometric analysis of granuloma cell popula-
tions, with a focus on macrophages and granulocytes as major
FcR expressing cells. As the absence of antibodies resulted in a
defective immune response already at day 4 post challenge
infection, we compared granuloma cell populations from
challenge infected JH
2/2 and wildtype mice by flow cytometry
using the gating strategy described in Fig. S2A. No significant
differences in the cellular infiltrate were noted between the two
strains, with the exception of basophils that were absent from the
granuloma of antibody-deficient mice (Fig. S2B). The absence of
basophils observed in JH
2/2 mice was in keeping with our
previous work, showing an important role for antibodies in
basophil expansion during Hp infection [40]. However, basophils
represent a minor cell population in the granuloma and
basophil depletion during challenge infection only had a minor
impact on protective immunity [40]. Thus, we concluded that
antibody-FcRc-chain-mediated protection is likely to involve
other cell types.
Granuloma macrophages express high levels of antibody
receptors and efficiently bind IgG1 and IgG3
The similarities in the cell recruitment between wildtype and
antibody deficient mice suggested that antibodies might differ-
entially activate resident or recruited cells at the site of infection.
As our previous data indicated a predominant role of IgG [30]
we analysed surface IgG on macrophages (F4/80high, Ly6G2),
eosinophils (SSChigh, SiglecF+) and neutrophils (Ly6G+ Gr1+) by
flow cytometry. Our analysis showed that macrophages, which
were the most abundant cell type in day 4 granulomas,
displayed the highest surface levels of IgG, with eosinophils
exhibiting moderate binding and neutrophils very little binding
(Fig. 2A, left panel). We then confirmed the different IgG
binding capacities of macrophages and eosinophils in vitro with
bone marrow derived cells incubated with Hp immune serum
(Fig. 2A, right panel). Further characterization of granuloma
macrophages by flow cytometry showed high surface expression
of activating FccRs (CD64 and CD16) as well as CD11b, which
is involved in complement-mediated immune complex binding
[41] (Figs. 2B, S2C). In addition, macrophages displayed low
levels of IgE but considerable levels of IgG1 and IgG3 on their
surface (Fig. 2C).
When comparing granuloma macrophages in challenge Hp
infected wildtype and FcRc2/2 mice, we observed that FcRc2/2
mice displayed reduced levels of surface IgG1 and IgG3 (Figs. 2C,
S2C). Interestingly CD11b levels were also reduced on granuloma
macrophages of FcRc2/2 mice (Fig. S2C). Thus, in addition to the
engagement of activating Fc receptors, helminth-antigen-antibody
immune complexes might bind to CD11b in a complement
dependent manner [42] [43] [44].
Antibodies act to upregulate Arginase-1 expression by
macrophages in vitro and in vivo
We next investigated potential differences in the activation of
macrophages in the presence or absence of specific antibodies
following challenge infection with Hp. As RNA samples from
granulomas were not of sufficient quality for microarray analysis,
we performed in vitro experiments with bone marrow-derived
macrophages (BMMac) that we incubated with Hp immune
serum (1:50, v:v) and infective Hp L3 larvae (500 larvae/106
cells). Gene expression was compared using microarray analysis
of macrophages incubated with larvae alone or with larvae in
combination with immune serum. The microarray analysis
identified a total of 216 genes that were differentially expressed
(up- or down- regulated more than 1.5 fold). Among the ten
most downregulated genes, we identified several TH1 associated
genes such as interleukin 12b (IL12b), interferon regulatory
factor 1 (Irf1) and interferon inducible GTPase 1 (Iigp1).
However for our further experiments, we focused on the ten
genes that were found to be upregulated more than two-fold by
the combination of immune serum and larvae. Of note, these
included several factors involved in tissue repair processes such
as angiogenesis, cell proliferation, and remodeling as well as
granulocyte recruitment and activation, or type 2 immunity
(Table 2). Subsequent qPCR analysis confirmed the significant
up-regulation of CXCL3, CXCL2, IL-33, Jag1 and Arg1 (Figs. S3,
3A). However, Arg1 was the only gene that was upregulated to a
lesser extent in macrophages from FcRc2/2 mice. Moreover, Arg1
was moderately upregulated when BMMac were stimulated with
larvae and purified 2u IgG (100 mg/ml), which could be greatly
enhanced, when naı¨ve serum was added together with 2u IgG and
larvae (Fig. S3J). Hence, helminth-specific IgG can reprogram
macrophages and this effect is amplified by the presence of
complement components.
We next investigated the impact of antibodies on Arg1 protein
expression by macrophages in vivo. Arg1 expression in granuloma
sections from wildtype, JH
2/2 or FcRc2/2 mice was analysed by
immunofluorescence and confocal microscopy (Fig. 3B). In
keeping with our gene expression data, granulomas of antibody-
deficient mice harbored significantly lower numbers of Arg1high
macrophages (Fig. 3B). Quantification of the intensities of the
Arg1 and F4/80 staining for each cell resulted in scatter plots,
which clearly showed that most F4/80+ cells expressed Arg1 in the
granuloma of C57BL/6 but not of FcRc2/2 or JH
2/2 mice
(Fig. 3C). Furthermore, significant differences were noted not only
for the frequency of Arg1high macrophages (Fig. 3D) but also for
the mean Arg1 intensity in all detected cells (Fig. 3E) and the total
Arg1 intensities in the region of interest (Fig. 3F). Of note, we
could not detect any Arg1 expressing cells in the granuloma of 1u
Hp infected C57BL/6 mice (Fig. 3G), indicating that effector
mechanisms that arise only following challenge infection are
required for Arg1 upregulation.
Table 1. Accession numbers for abbreviations of gene name
used in the text.
Gene name Accession number (UniProt)
Arg1 Q61176
C3 P01027
CD11b A1E2I0
CD16 P08508
CD64 P26151
CD32 P08101
CXCL2 Q6PUJ1
CXCL3 Q6W5C0
FcRc Q8AY96
IL4 P07750
IL4Ra´ P16382
IL13 20109
IL33 Q8BVZ5
Jag1 Q9QXX0
JH Q9QXF0
doi:10.1371/journal.ppat.1003771.t001
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Immune serum from challenge-infected mice induces the
adherence of macrophages to Hp larvae in vitro
In our in vitro co-cultures of bone marrow derived macrophages
(BMMac) and larvae, we observed that immune serum from
challenge Hp infected C57BL/6 mice (collected at day 4 p.i.)
induced the adherence of macrophages to larvae (Fig. 4A). By
contrast, serum from 1u Hp infected C57BL/6 or challenge Hp
infected JH
2/2 mice showed an attenuated capacity to induce
macrophage adherence (Fig. 4A). Immune serum-induced adher-
ence could be confirmed using macrophages from the peritoneal
cavity of naı¨ve mice (Fig. S4A), or using BMMac of a different
genetic background (Balbc) (Fig. S4B). As IgG+ eosinophils were
also present in the granuloma, we additionally tested the ability of
these cells to adhere to larvae. Bone marrow-derived eosinophils
activated with immune serum hardly adhered to larvae, and
addition of these cells to macrophage cultures decreased rather
than increased macrophage adherence (Fig. S4B). These data
indicate that Hp-specific antibodies predominantly act on macro-
phages to promote cellular adherence to larvae.
To rule out a possible contribution of IL-4 from immune serum
we determined the role of this cytokine in macrophage adherence.
Addition of IL-4 to macrophage larvae co-cultures did not alter
immune serum-induced macrophage adherence and larval immo-
bilization (Fig. S5A) or larval fitness (Fig. S5B), and levels of IL-4
or IL-13 present in the immune serum or macrophage-larvae co-
culture supernatants were all below the ELISA detection limit
(Figs. S5C, D).
Macrophages immobilize Hp larvae in an antibody-, FccR-
and complement-dependent manner
We also noted that larvae covered in helminth-antibody
activated macrophages exhibited a striking reduction of larval
Figure 1. Antibody and FcRgamma-chain deficient mice show increased larval burdens, larger granulomas, a stronger tendency to
develop necrosis and higher in-tissue motility as compared to wildtype mice. Mice were challenge infected with 200 infective L3 larvae
after drug cured 1u infection and sacrificed on day 4 p.i.; (A) Numbers of tissue invasive larvae were analysed with a modified Baermann apparatus. (B)
Paraffin sections of the duodenum of infected mice were hematoxylin and eosin (H&E) stained, (C/D) granuloma areas were quantified in light
microscopy images of the largest cross-section of serial sections with larvae (C) or without larvae (D). (E) Necrosis in H&E-stained sections was scored
by a blinded pathologist. (F–H) Absolute (F) and relative (H) in-tissue motility or larval length (G) was assessed by light microscopy combined with our
Fiji macro. Pooled data of two independent experiments with 5 mice per group are shown as mean + SEM (*p,0.05, **p,0.01, ***p,0.001, Mann-
Whitney test).
doi:10.1371/journal.ppat.1003771.g001
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motility. To analyze this in a quantitative manner we developed a
method to analyze larval motility in time-lapse movies. This
analysis showed a clear correlation between the number of
adherent macrophages per larvae and the reduction in larval
motility, measured as the difference in the larval shape between
consecutive frames of time-lapse movies (Fig. 4B) (detailed
description Fig. S1B–D). We next explored the role of activating
FcRs and complement in immune serum-induced macrophage
adherence to Hp larvae. When co-cultured with larvae in the
presence of immune serum, FcRc2/2 macrophages adhered less
efficiently to larvae as compared to wildtype macrophages
(Fig. 4C). Using BMMac from mice lacking all IgG receptors
(FccRI/II/III/IV2/2), we confirmed the important role of IgG
for efficient trapping of larvae (Fig. S4E). As expected, FccRI/II/
III/IV2/2 displayed no detectable surface IgG, CD16/32
(FccRII/III) or CD64 (FccRI) and both FccRI/II/III/IV2/2
and C57BL/6 BMMac did not show IgM binding (Fig. S4F). To
rule out a possible role of IgE for larval trapping, we studied
macrophage adherence and larval immobilization, using immune
serum from challenge infected IgE2/2 mice. IgE-deficient
immune serum potently induced BMMac adherence as well as
larval immobilization (Figs. S4G, H).
As for FcRc2/2 mice, our previous work had shown a small but
significant contribution of complement to reducing adult worm
numbers following challenge Hp infection [30]. Thus to determine
a possible contribution of complement in larval immobilization we
used complement component 3 (C3)-deficient immune serum in
our macrophage assays. C3-deficient immune serum had a clearly
reduced ability to promote macrophage adherence to wildtype
macrophages and adherence of macrophages from FcRc2/2 mice
was completely abolished (Fig. 4C). Moreover, FcRc2/2 macro-
phages had a lower capacity to trap larvae in the presence of
wildtype immune serum, and failed completely to immobilize
larvae when incubated with C3-deficient immune serum (Figs. 4D/
E) (Movie S2). These data indicate that immune serum acts to
promote macrophage adherence and larval immobilization in a
manner involving the contribution of activating FcRs and
complement.
Of note, immune serum also triggered adherence of BMMac to
tissue dwelling L4 stage larvae, which we recovered from the small
intestine of infected mice. Although L4 larvae were less motile
than infective L3 larvae, immune-serum induced macrophage
adherence also had a negative effect on their motility in vitro
(Movie S3).
In order to study a potential effect of immune serum-induced
macrophage adherence on larval fitness, we next infected mice
with larvae recovered from immune serum-supplemented macro-
phage co-cultures. Adult worm counts on day 10 p.i. indicated
that larvae cultured with BMMac and immune serum for 24h
were still as infective as larvae cultured with macrophages alone
(Fig. 4F). As another measure of larval fitness, we quantified ATP
levels in larval homogenates following their recovery from
macrophage co-cultures. Again we could not detect any significant
difference in the viability after culture with BMMac alone, or with
a combination of immune serum and BMMac (Fig. 4G). Taken
together these data suggest that helminth-antibody-dependent
macrophage activation promotes their adherence to result in an
impact on larval motility but not on larval viability.
Absence of Arginase-1 reduces immune serum-induced
larval trapping
Our previous data demonstrated that antibody-FccR interactions
upregulated Arg1 gene expression in macrophages co-cultured with
larvae in vitro, and were necessary for Arg1 protein expression by
granuloma macrophages in vivo. Moreover Arg1 has previously been
reported to contribute to protective immunity against Hp [16]. We
therefore investigated a possible contribution of this enzyme to
macrophage adherence and larval immobilization. We performed in
vitro co-cultures of bone marrow-derived macrophages from
Arg1f/fTie2-Cre [45] [46] or Tie2-Cre [47] mice with Hp larvae
in the presence of immune serum. The Tie2-Cre deleter was
originally reported to result in Cre recombinase mediated gene
ablation in endothelial cells [47], but was later discovered to show
robust (80–90%) recombination also in hematopoietic cells [48]. We
confirmed Arg1f/f and Tie2-Cre transgene expression and partial
deletion of Arg1 in Arg1f/fTie2-Cre mice (Figs. S5H–J). We could
not observe any difference in the capacity of Arg1f/fTie2-Cre and
wildtype Arg1Tie2-Cre macrophages to adhere to larvae (Fig. 5A).
However, Arg1f/fTie2-Cre macrophages had a reduced ability to
immobilize larvae after incubation with immune serum (Figs. 5B, C)
(Movie S4). To further confirm the role of Arg1 in antibody-
mediated larval trapping, we added the Arg1 inhibitor S-(2-
boronoethyl)-L-cysteine (BEC) to co-cultures of BMMac and larvae
in the presence of immune serum. Addition of BEC in vitro resulted
in reduced macrophage adherence and clearly impaired larval
immobilization (Figs. 5, E).
Finally, we tested the relevance of Arg1 in larval trapping in vivo,
by treating challenge-infected C57BL/6 mice with BEC (0.2%,
oral gavage, once daily). In keeping with previous findings [16],
BEC treatment resulted in higher larval burdens (Fig. 5F).
Moreover, larvae in BEC treated mice showed higher in-tissue
motility (Fig. 5G, Movie S5).
Arg1 catalyzes the breakdown of L-Arginine into urea and L-
ornithine, and BMMac produced considerable amounts of urea
when activated with immune serum and Hp larvae (Fig. S5F). We
first investigated a potential effect of L-arginine depletion by
culturing larvae in L-arginine-free medium. However, we did not
observe significant changes in the larval motility in the absence of
L-arginine (Fig. 5H). As larvae are surrounded by large numbers
of Arg1 expressing macrophages in challenge Hp infected mice,
trapped larvae are likely to be exposed to high levels of Arg1
products. To replicate this process in vitro we incubated larvae with
L-ornithine or polyamines (putrescine, spermidine and spermine)
or urea. While urea did not significantly affect larval motility (even
at 100 mM) (Fig. 5I), L-ornithine and polyamines clearly impaired
larval movement (Fig. 5H, Movie S6). These data implicate L-
arginine metabolism to polyamines as a possible mechanism by
which Arg1 contributes to protective immunity against Hp.
Antibodies can induce Arg1 independently of IL-4Ra
signaling
IL-4 has long been recognized as a major factor responsible for
the upregulation of Arg1 [49]. Thus, we analysed Arg1 expression
in BMMac after culture with larvae and immune serum in the
presence of IL-4. IL-4 alone clearly induced Arg1 to similar levels
as observed for immune serum (Fig. 6A), and the combination of
IL-4 plus immune serum resulted in a slightly stronger Arg1
induction, both on the mRNA and enzymatic activity level
(Figs. 6A, B).
Arg1 expression during helminth infection is normally associ-
ated with an AAM phenotype dependent upon IL-4Ra signaling
[49] [16] [50]. Hence, we further investigated the role of IL-4Ra
signaling on antibody-induced upregulation of Arg1 following
challenge Hp infection. As IL-4Ra2/2 mice exhibit a strongly
impaired antibody response during primary and challenge
infections with Hp [40], we treated challenge-infected mice with
immune serum (collected at day 4 p.i.) from immune C57BL/6
mice. As shown in Fig. 6C, IL-4Ra2/2 mice showed reduced
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Figure 2. Macrophages are the major IgGhigh population in the granuloma following challenge Hp infection and express high levels
of antibody and complement receptors. (A) 25–30 granuloma were excised from the small intestine of challenge Hp infected mice on day 4 p.i.
and isolated granuloma cells (left panels) or immune serum activated bone marrow derived cells (right panels) were stained for cell surface markers
and IgG. (B) Expression of CD64, CD16/32 and CD11b on granuloma macrophages from C57BL/6 or FcRc2/2 mice; (C) Levels of IgE, IgG1 and IgG3 on
granuloma macrophages from C57BL/6 or FcRc2/2 mice; Representative FACS plots from two independent experiments with 4–5 mice per group are
shown.
doi:10.1371/journal.ppat.1003771.g002
Table 2. Fold induction and function of the 10 most upregulated genes in macrophages co-cultured with immune serum in
combination with larvae as compared to larvae alone.
Gene name Fold change Function (with relation to macrophages)
CXCL3 8.7 Granulocyte recruitment & activation [74], angiogenesis [75]
Jag1 2.6 Angiogenesis [76], TH cell differentiation [77]
Emp2 2.6 Cell adhesion [78], angiogenesis [79]
Trem1 2.5 Induction of immune responses [80],[81], inflammatory response to Schistosoma [82]
Tpbpa 2.4 Placental function & maternal vasculature remodeling [83]
CXCL2 2.4 Granulocyte recruitment & activation [74]
S100A8 2.3 Stress response [84], immune regulation & wound healing [85]
Arg1 2.3 Wound healing, immune regulation [46], immunity to helminths [16]
Il33 2.2 Induction of TH2 response [86] (activation of basophils, eosinophils, TH2 cells)
Inhba 2.1 Cell growth [87], TH2 cytokine & inducer of alternative activation [88]
Bone marrow derived macrophages (106/ml) were cultured with larvae (500/ml) in the presence or absence of immune serum. Cells were detached from plates or larvae
and passed through 40 mm filters before collection for RNA extraction. Changes in gene expression were identified by whole mouse genome microarray (Affymetrix)
and confirmed by qPCR (for genes in bold). For a description of the microarray analysis, see Text S1.
doi:10.1371/journal.ppat.1003771.t002
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numbers of F4/80+ macrophages surrounding tissue dwelling
larvae. However, treatment with immune serum did result in an
increase in Arg1+ macrophages within the granuloma of IL-
4Ra2/2 mice, indicating that Hp-specific antibodies can induce
Arg1 expression in vivo independently of IL-4Ra signaling
(Figs. 6C, D). To confirm that the ability of antibodies to trigger
Arg1 expression in macrophages occurs independently of IL-4Ra
signaling, we performed co-cultures of IL-4Ra2/2 BMMac with
Hp larvae. As shown in Fig. 6E, Arg1 was potently upregulated in
IL-4Ra2/2 BMMac in response to immune serum and larvae.
Taken together these data indicate that IL-4 and antibodies can
upregulate expression of Arg1 independently, but when present
together will act in an additive manner.
Lastly, we investigated a potential role of IL-4Ra and other
effector mechanisms that may contribute to immune serum-
triggered larval trapping by macrophages. We observed that IL-
4Ra2/2 BMMac displayed a significantly reduced capacity to
adhere (Fig. 6F), but were still able to immobilize larvae (Fig. 6G).
Furthermore, IgG antibodies purified from challenge immune
serum promoted weak adherence and moderate larval immobiliza-
tion, which could be greatly enhanced by naı¨ve serum (Figs. 6H, I).
These data suggest that helminth specific antibodies together with
complement components can trigger larval trapping even in the
absence of other effector molecules that may be present in challenge
immune serum.
Discussion
Numerous studies have documented a role for antibodies in
providing protective immunity against helminths [34] [35] [36]
[51] [37] [28] [30] [29], yet the mechanisms by which antibodies
act against these large multicellular parasites have remained
elusive. Our current work demonstrates a novel effector function
of antibodies in activating macrophages to modulate the expres-
sion of genes normally associated with the alternatively activated
phenotype. Antibody-mediated macrophage activation also trig-
gered macrophage adherence to helminth larvae and resulted in a
potent suppression of larval motility.
Interestingly, activating Fc receptors and complement C3
component acted together to activate macrophages and to limit
larval motility in vitro. Crosstalk between the complement cascade
and activating Fc receptors is well known to occur in autoimmunity
[52]. We have previously shown that genetic ablation of either
FcRc-chain or the complement component C3 led to a significant
Figure 3. Arg1 is induced by immune serum and Hp larvae in vitro and Arg1 expressing macrophages are less abundant in the
granulomas from antibody and FcRgamma-chain deficient mice. (A) Arg1 expression in BMMac from C57BL/6 or FcRc2/2 mice cultured in
the presence or absence of larvae and/or immune serum was quantified by qPCR. (B) Paraffin sections of the upper duodenum of challenge Hp (day
4 p.i.) infected C57BL/6, FcRc2/2 or JH
2/2 mice were immune-fluorescently stained for Arg1 (green), F4/80 (red) and nuclei (blue), representative
pictures are shown. (C–F) Intensities of Arg1 and F4/80 were quantified using Fiji and Cell Profiler software. (C) Scatter plots of intensities for F4/80
and Arg1 for all detected cells in the region of interest (ROI) (D) Frequency of Arg1+ F4/80+ (intensity .0.035) cells in the ROI, (E) Mean intensity of
Arg1 and F4/80 staining in all detected cells in the ROI (F) Total intensity of Arg1 and F4/80 staining per ROI; Pooled data from two independent
experiments with 3–6 mice per group are shown as mean + SEM (*p,0.05, **p,0.01); (G) Arg1+ macrophages are absent from the granuloma of 1u
Hp infected mice (day 14 p.i.), representative picture.
doi:10.1371/journal.ppat.1003771.g003
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but minor defect in the emergence of adult worms following
challenge Hp infection between days 14–28. Our current data
suggest that these two pathways act in a redundant and additive
manner to promote antibody-induced larval trapping and to
provide immunity against challenge Hp infections. The rapid
activation of cells via Fc receptors is likely to be of particular
importance during the early response (day 4) against the tissue
dwelling larvae, as mice genetically deficient for FcRc or B cells
exhibited similar increases in larval motility and tissue necrosis
within intestinal granulomas. The tissue dwelling stage of helminth
larvae has been suggested to be a primary target of antibody-
mediated protective immunity, which may be advantageous due to
the immune-suppressive capacities of adult worms [53]. Our data
further suggest that the antibody-mediated activation of granuloma
macrophages mainly involves IgG1 and/or IgG3 isotypes, which
may form immune complexes with helminth antigens or directly
bind to the larval surface. As essential components of the larval
cuticle are shared between different helminths, future work should
delineate the specificities of protective antibody isotypes in order to
identify potential vaccine targets.
Interestingly, although immune serum efficiently activated
macrophages to immobilize larvae in vitro, it did not impact on
larval viability. Given that the destruction of a large extracellular
parasite such as Hp is likely to result in severe inflammation, the
trapping and starvation of invasive larvae might be more beneficial
for the host. In line with this view we observed that type 2-
associated antibody production functioned to limit tissue necrosis
and to induce tissue repair genes. Thus, type 2 immunity may act
to limit larval migration through tissues, leading to a halt in the
parasitic lifecycle and additionally serving to prevent excessive
tissue damage. However we cannot rule out the possibility that
other immune-mediated mechanisms also contribute to the killing
of helminth larvae in vivo.
Of particular interest, arginase was required for the ability of
helminth-antibody activated macrophages to inhibit larval motility as
well as for efficient larval trapping in vivo. Arg1 expressing AAM are
strongly associated with helminth infection [16] [54] [46] [55], and
are typically regarded as controlling inflammation and tissue repair
[46] [55] rather than as protective immune cells [56]. However, in
keeping with our data Anthony et al. [16], previously reported a
Figure 4. Antibodies from challenge Hp infected wildtype mice induce adherence of bone marrow derived macrophages to Hp
larvae in vitro, causing larval immobilization dependent on FcRgamma-chain and complement component 3; Larval infectivity and
viability is not affected by adhering macrophages. (A) BMMac from C57BL/6 mice were co-cultured with larvae in the presence or absence of
serum from 1u or challenge Hp infected C57BL/6 or JH
2/2 mice, adherent macrophages per larva were counted in light microscopy images. (B)
Correlation of the number of adhering BMMac and larval motility, (C/D) C57BL/6 or FcRc2/2 BMMac were cultured with larvae in the presence or
absence of immune serum from C57BL/6 or FcRc*C32/2 mice. Adherent macrophages per larva were counted in light microscopy images (C) and
larval motility was quantified by Fiji (D). (E) Representative time lapse pictures, (F) Larval infectivity was analysed by infecting C57BL/6 wildtype mice
with 100 larvae recovered from BMMac co-cultures in the presence or absence of immune serum. Adult worms in the three parts of the small
intestine were counted on day 10 p.i.. (G) The larval viability relative to control (cultured without BMMac) after co-culture with or without immune
serum was quantified by ATP-assay. Pooled data from three independent experiments with bone marrow from 2–3 mice or with 5 mice per group are
shown as mean + SEM (*p,0.05, **p,0.01, ***p,0.001, Mann-Whitney test).
doi:10.1371/journal.ppat.1003771.g004
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protective role for Arg1 expressing AAM in Hp infection. Our work
expands on these findings to indicate that antibodies are essential for
the robust Arg1 expression by macrophages following Hp infection.
We also show that the Arg1 product L-ornithine and the polyamine
metabolites putrescine, spermidine and spermine have a direct
negative effect on larval motility, suggesting that excessive polyamines
can impact on larval metabolism in a manner that interferes with
motility. The finding that L-ornithine immobilizes larvae at
concentrations that are below usual serum levels of this metabolite
(around 50 mM) is surprising especially as granuloma may be
expected to be a ‘‘leaky’’ environment. However, under homeostatic
conditions, cell-free L-ornithine levels in the intestine might be
relatively low due to the co-expression of Arginase 2 and L-ornithine
metabolizing enzymes in enterocytes [57]. Thus, Arg1 activity might
serve not only to control aberrant inflammation and fibrosis during
parasite infection [46], but to also create a metabolically unfavorable
environment for parasites. Future studies will be required to delineate
the exact mechanism(s) by which polyamines affect larval motility.
Of note, IL-4Ra2/2 mice failed to accumulate the large
numbers of macrophages that were observed in the granuloma of
wildtype mice, indicating that IL-4Ra signaling is necessary for the
recruitment and/or expansion of macrophages at the site of
infection [16] [58]. Thus, even if macrophages could immobilize
larvae in the absence of IL-4Ra signaling in vitro, IL-4Ra signaling
might be essential for the accumulation of macrophages in vivo,
which can then be activated by antibodies to immobilize tissue
invasive larvae. This suggests that in vivo, antibodies and IL-4 may
work together to elicit a potent activation of Arg1 expressing
macrophages, which mediate protection. This might be due to the
convergence of IL-4Ra and FcRc-chain signaling at the level of
downstream signaling events such as Spleen tyrosine (Syk) or PI3
kinases [59] [60] [61]. In a lung model of Schistosoma infection,
Arg1 expression in the granuloma was found to be tightly
concentrated around the egg despite abundant AAM and type 2
cytokines (IL-4 and IL-13) in the overall granuloma environment
[25]. Thus, it is tempting to speculate that antibodies directed
Figure 5. Arg1 is needed for to efficient larval trapping in vitro and in vivo and L-ornithine or polyamines but not urea can reduce
larval motility in vitro. (A/B) BMMac from Tie2-Cre or Argf/fTie2-Cre mice were co-cultured with larvae in the presence or absence of immune serum
from C57BL/6 mice and adherence (A) and motility (B) were assessed by light microscopy. Dashed line in panel B depicts motility of larvae in the
presence of BMMac without addition of immune serum. (C) Representative time lapse pictures; (D/E) Adherence and motility of C57BL/6 BMMac in
the presence of the Arg1 inhibitor BEC (1 mM); (F/G) C57BL/6 mice were treated with BEC (0.2%) during challenge infection and larval motility (F) and
numbers (G) were analysed; (H/I) Larvae were cultured in L-arginine free medium with or without supplementation with L-arginine (570 mM) +/2 L-
ornithine, putrescine, spermidine or spermine (each 100 mM) (H) or urea (I) and motility was quantified. Pooled data from two independent
experiments (3–6 mice per group) are shown as mean + SEM (*p,0.05, **p,0.01, ***p,0.001, Mann-Whitney test).
doi:10.1371/journal.ppat.1003771.g005
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Figure 6. Antibodies can induce Arg1 and larval trapping by macrophages independently of IL-4Ralpha signaling. (A) Arg1 expression
in BMMac treated with larvae and immune serum and/or IL-4 or was quantified by qPCR and calculated relative to untreated control (B) Urea
production in macrophages (treated as in (A)) was quantified after performing an Arg1 activity assay. (C) Sections of the small intestine from
challenge-infected C57BL/6 or IL-4Ralpha2/2 mice, treated with immune or naı¨ve serum were stained for Arg1 (green) and F4/80 (red) and
counterstained with DAPI (blue). Representative pictures from two independent experiments with 3–4 mice per group are shown. (D) Frequencies of
Arg1+F4/80+ cells, mean intensities or total intensities of Arg1 and F4/80 were quantified using Fiji and Cell Profiler software. Dashed line depicts
background fluorescence (E). Arg1 expression in wildtype or IL-4Ralpha2/2 BMMac treated with larvae and immune serum was quantified by qPCR.
(F/G) BMMac adherence (F) and larval motility (G) were analysed after co-culture with larvae in the presence or absence of immune serum. (H/I)
Adherence (H) and motility (I) after treatment with larvae and purified 2u IgG 2/+ naı¨ve serum (NS). Dashed line depicts motility of larvae with BMMac
alone. Pooled data from two independent experiments with 3–4 mice per group are shown as mean + SEM (*p,0.05, **p,0.01, ***p,0.001, Mann-
Whitney test).
doi:10.1371/journal.ppat.1003771.g006
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against helminth eggs or larvae can promote local Arg1 expression
in areas of high antigen availability.
Previous publications have indicated that macrophages activated
by type 2 cytokines express high levels of Arg1 [16] [49] [27], whilst
macrophages activated by immune complexes and TLR ligands in
vitro express high levels of IL-10 and low levels of Arg1 [62]. In our
hands, antibodies together with helminth larvae elicited potent Arg1
expression even in the absence of IL-4Ra signaling. Interestingly,
immune complexes were previously shown to induce a robust FcR-
and complement-mediated activation of C/EBPbeta, and C/
EBPbeta has previously been associated with Arg1 induction in
response to bacterial infection [63] [45], indicating it may also play
a role in our model. Importantly the prominent expression of Arg1
by helminth-antibody activated macrophages did not correlate with
other markers typical of AAM, such as Relma. Thus the helminth-
antibody activated macrophages described in this study seem to
represent a novel ‘‘regulatory’’ macrophage type, which expresses
Arg1 and wound healing genes in the absence of Relma. The exact
role of these helminth-antibody activated macrophages in tissue
repair during the resolution phase of intestinal helminth infection
would be of great interest for future studies.
In addition to the ‘‘canonical’’ pathway of Arg1 induction via
the IL-4/IL-13/Stat6 pathway [64], Arg1 expression can be
elicited via MyD88/IL-6/Stat3 and adenosine dependent mech-
anisms [65] [66]. Here, we have identified a novel pathway, which
leads to the induction of Arg1 in the context of an adaptive type 2
response and which involves antibody-helminth interactions. The
existence of multiple pathways for the induction of Arg1 may serve
to achieve redundancy in an essential anti-inflammatory effector
mechanism functional in many settings of infection, inflammation
and wound healing.
In summary, we have demonstrated that antibodies mediate the
activation of macrophages resulting in Arg1 expression and
immobilization of tissue invasive helminth larvae. Macrophages
often form a large component of the inflammatory infiltrate
following allergen challenge or helminth infection, and our data
indicate that antibodies form a previously unrecognized compo-
nent of macrophage regulation during type 2 immune responses.
Materials and Methods
All animal experiments were approved by the office Affaires
ve´te´rinaires (1066 Epalinges, Canton Vaud, Sitzerland) with the
authorization Number 2238 according to the guidelines set by the
service de la consummation et des affaires ve´te´rinaires federal
(Canton Vaud, Switzerland).
Mice
C57BL/6, BALB/c, JH
2/2, FcRc-chain2/2 [67], C32/2 [68],
IgE2/2 [69] and IL-4Ra2/2 [70] were bred and maintained
under specific pathogen free conditions at the Ecole Polytechnique
Fe´de´rale (EPFL) de Lausanne, Switzerland. FccRI/II/III/IV2/2
mice were bred and maintained at Leiden University, Netherlands
and Arg1fl/flTie2-Cre [45] and Tie2-Cre [47] mice were bred and
maintained at New Jersey Medical School, USA. The following
primers were used for genotyping of Arg1fl/flTie2-Cre mice:
wildtype Arg1/Arg1fl/fl: 59-TGCGAGTTCATGACTAAGGT-
T-39 (forward), 59-AAAGCTCAGGTGAATCGG-39(reverse);
Tie2-Cre: 59-CGCATAACCAGTGAAACAGCATTGC-39 (for-
ward) 59-CCCTGTGCTCAGACAGAAATGAGA-39 (reverse).
Infection, parasitology and collection of immune serum
C57BL/6 mice were infected with 200 Hp L3 larvae by oral
gavage. Worms were cleared by treatment with two courses of
Cobantril (Interdelta - Givisiez, Fribourg, Switzerland) 28 days
after primary infection. 14 days later mice were challenge-infected
with 200 larvae. BEC (Cayman Chemicals, Ann Arbor, MI) was
administered (0.1 ml, 0.2%) once daily from the first day of
infection by oral gavage. Mice were sacrificed on day 4 post
infection and immune serum was collected from the inferior vena
cava. Adult worms were counted under a stereomicroscope on
longitudinally opened small intestines of 1u or challenge-infected
mice. Tissue dwelling L4 larvae were counted after recovery with a
modified Baermann apparatus [16].
Histology, immunofluorescence stainings and confocal
microscopy
Serial paraffin sections were stained with hematoxylin and eosin.
Granulomas were identified by light microscopy and serial sections
were used for pathological scoring (details see Text S1) or
immunofluorescence staining for Arginase-1 and F4/80. Stained
tissue sections were imaged with an inverted point scanning confocal
microscope (Zeiss LSM 710) with a Plan-Apochromat (636/1.4 NA
or 406/1.3 NA) objective and pixel intensities were analysed using a
custom built CellProfiler pipeline (for details see Text S1).
Flow cytometry
In vitro cultured cells or cells isolated from granuloma were
stained with fluorescently labeled monoclonal antibodies (see Text
S1) and acquired on a BD LSRII flow cytometer (BD, Franklin
Lakes, NJ).
Luminescent Cell Viability Assay for assessment of larval
viability
Larvae were recovered from co-cultures with macrophages with
or without immune serum, washed thoroughly with enzyme free
cell dissociation solution (Milipore, Billerica, MA) to remove all
adherent cells, counted and homogenized in a cell/tissue
homogenizer in RPMI1640 by using 0.1 mm Zirconia/Silica
beads (BioSpec Products, Inc.). ATP levels in larval homogenates
were analysed by CellTiter-Glo Luminescent Cell Viability Assay
(Promega, Madison, WI).
Culture and treatment of murine bone marrow cells and
peritoneal macrophages
Peritoneal macrophages were isolated by plating peritoneal
wash cells on petri dishes overnight and by removing non-
adherent cells. Bone marrow was flushed from the femur and tibia
of wildtype or transgenic mice and passed through cell strainers
(70 mm). Cells (106/ml) were cultured in M-CSF (L929) supple-
mented medium (RPMI, 10% FCS, penicillin/streptomycin, b-
mercaptoethanol) for 7 days as described previously [71]. On day
7, macrophages were harvested and stimulated for 24 h as
indicated with L3 larvae (500 larvae/106 cells),(10 ng/ml)
(Peprotech, Rocky Hill, NJ), or immune sera (1:50 v/v). For
differentiation into eosinophils, bone marrow cells were cultured as
described [72] in the presence of Flt3 and SCF (Peprotech, Rocky
Hill, NJ) for 4 days and in the presence of IL-5 (Peprotech, Rocky
Hill, NJ) for subsequent 8 days. For RNA extraction, cells were re-
suspended in Trizol and kept at 280uC.
Adherence of macrophages to larvae was determined by manual
counting of bright field microscopy pictures taken with an
Olympus AX70 microscope (UPLAN 106/0.3 NA objective).
Measurement of larval motility
Time-lapse series (60 s: 20 frames, 3 s intervals) of larvae in the
small intestine ex vivo or in vitro were acquired in order to measure
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their motility with an Olympus AX70 microscope (UPLAN 106/
0.3 NA objective). Larval motility was quantified by using custom-
made Fiji macros (for details see Text S1).
qPCR and microarray analysis
RNA was extracted with a Direct-zol RNA MiniPrep kit (Zymo
Research, Irvine, CA) and reverse transcribed using RevertAid
cDNA synthesis reagents (Thermo Scientific, Waltham, MA) for
qPCR analysis. QPCR was performed using SYBR Green I Master
Mix (Eurogentec, Liege, Belgium) on an Applied Biosystems
7900HT System (for qPCR primer sequences see Table S1).
Microarray analysis was performed using Affymetrix mouse arrays
(Affymetrix, Santa Clara, CA, USA) (for details see Text S1).
ELISA
Concentrations of IL-4 or IL-13 in cell culture supernatants or
mouse serum were quantified by using ELISA Ready-SET-Go!
Kits (eBioscience, San Diego, CA).
Arginase-1 activity assay
Macrophage arginase-1 activity was determined according to
previously published methods [73]. Briefly, adherent macrophages
were lysed and conversion of L-arginine was quantified indirectly
by measuring urea production with a QuantiChrom Urea Assay
(BioAssay Systems, Hayward, CA).
Supporting Information
Figure S1 Image processing for motility analysis ex vivo
and in vitro and quantification of immune-fluorescent
staining for Arg1 and F4/80. (A) First (a) and last (a9) frame of
an ex vivo time-lapse acquisition. Mask obtained for the first (b) and
last (b9) frame based on a manual drawing. XOR operator on first
and last frame masks (c). Common parts to both masks become
null (black) due to the XOR operation. (B) Montage of time-lapses
series of a larva co-cultured with macrophages (Arg1f/fTie2-Cre)
and immune serum in vitro (10 frames, 3 s interval). (C) Steps of the
image processing. (a) Raw images, (b) ‘‘find edges’’ filtered images,
(c) ‘‘median filter’’ filtered image, (d) ‘‘threshold manually
selected’’ segmented image. (D) Temporal color code of the z-
projection of mask series using the ‘‘Spectrum’’ look-up table (a).
Z-Projections of mask (b, b9), contour (c, c9) and convex hull (d, d9)
obtained for the time-lapses series from an in vitro experiment using
knock-out (KO) (Arg1f/fTie2-Cre) (b, c, d) or wildtype (WT)
(C57BL/6) macrophages (b9, c9, d9). (E) Original DAPI staining
image (a), nuclei identified (b) and their outlines on the DAPI
staining image (c); expanded nuclei mask used to measure in F4/
80 and Arg1 channels (d).
(PDF)
Figure S2 Except for basophils, granuloma cell popula-
tions are largely overlapping in challenge Hp infected
wildtype and antibody deficient mice. (A) Gating strategy
for the flow cytometry analysis of granuloma cell populations; (B)
Characterisation of granuloma cell populations in C57BL/6 and
JH
2/2 mice on day 4 post challenge infection according to the
gating strategy in (A). (C) MFI of CD11b, IgG1 and IgG3 on
granuloma macrophages from challenge infected C57BL/6 and
FcRc2/2 mice. Pooled data from two independent experiments
with 4–6 mice per group are shown as mean + SEM (*p,0.05,
**p,0.01).
(PDF)
Figure S3 Immune serum in combination with Hp
larvae induces the expression of genes involved in
granulocyte recruitment and activation, TH2 responses
and wound healing and purified 26 IgG in combination
with naı¨ve serum upregulates Arg1 expression. mRNA
levels normalized to GAPDH expression and relative to untreated
cells for Cxcl3 (A), Cxcl2 (B), Il33 (C), Jag1 (D), S100A8 (E), Emp2
(F), Tpbpa (G), Trem1 (H), Inhba (I) or Arg1 (J). (A–I) Expression of
the ten most-upregulated genes in BMMac treated with immune
serum and larvae versus larvae alone identified by microarray was
analysed by qPCR using cDNA from BMMac from C57BL/6 or
FcRc2/2 mice cultured in the presence or absence of larvae and/
or immune serum. (J) Expression of Arg1 after treatment with
purified 2u IgG 2/+ naı¨ve serum. Pooled data from three
independent experiments with bone marrow from 2–3 mice per
group are shown as mean + SEM (*p,0.05, **p,0.01,
***p,0.001, Mann-Whitney test).
(PDF)
Figure S4 Antibody-induced adherence to Hp larvae
occurs in different types of macrophages but not
eosinophils and is independent of IgE but dependent
on Fc receptors and IgG. (A) Adherence of peritoneal
macrophages to larvae in response to immune serum from 1u
and challenge Hp infected C57BL/6 mice. (B) Immune serum does
not induce adherence of bone marrow derived eosinophils to Hp
larvae. (C/D) Eosinophils fail to immobilize larvae. (E) FccRI/II/
III/IV2/2 macrophages show reduced larval trapping. (F) Surface
levels of IgG, IgM, CD16/32 (FccRIII/II) and CD64 (FccRI) on
C57BL/6 and FccRI/II/III/IV2/2 macrophages was analysed
by flow cytometry; (G/H) Immune serum from IgE2/2 mice
efficiently induces adherence (G) and immobilization (H); CD16
deficient macrophages show normal immune serum induced
adherence (G) and a minor defect in larval immobilization (H);
Peritoneal macrophages from C57BL/6 mice or BM-derived
macrophages or eosinophils from C57BL/6, BalbC, or FccRI/II/
III/IV2/2 mice were co-cultured with larvae in the presence or
absence of immune serum from Hp infected C57BL/6, BalbC or
IgE2/2 mice for 24 h. Adherent macrophages per larva were
counted in light microscopy images. Larval motility was quantified
by Fiji (as described in Experimental Procedures). Immune serum
activated BMMac were stained for surface IgG, IgM and antibody
receptors. Pooled data and representative histograms from two
independent experiments with peritoneal wash or bone marrow
from 2–4 mice per group are shown as mean + SEM (*p,0.05,
**p,0.01, ***p,0.001, Mann-Whitney test).
(PDF)
Figure S5 Presence of IL-4 does not change adherence
or larval viability in co-cultures with macrophages and
immune serum and co-culture supernatants contain
negligible levels of IL-4 and IL-13; Genotyping and
deletion efficiency for Arg1f/fTie2-Cre mice. (A-C)
BMMac were cultured with larvae or larvae and immune serum
(IS) in the presence or absence of IL-4 (10 ng/ml) for 24 h. (A/B)
Macrophage adherence and larval motility were determined by
light microscopy. (C) Larval viability was assessed by CellTiter-Glo
Assay and normalized to the larval viability after culture for 24 h
in BMMac medium without BMMac or IS. (D-G) IL-4 or IL-13 in
serum (D/E) or cell culture supernatants (F/G) was quantified by
ELISA. (H/I) Arg1f/f, WT Arg1 or Tie2-Cre transgene expression
was determined in tissue biopsies from Arg1f/fTie2-Cre or Tie2-
Cre mice. (J) Relative expression of Arg1 mRNA was determined
in BMMac from the same mice as in H/I. Data from two
independent experiments are shown as mean + SEM (***p,0.001,
Mann-Whitney test).
(PDF)
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Movie S1 In vivo motility of larvae in granuloma of
antibody and FcRc deficient versus wildtype mice. A piece
of the upper duodenum of challenge Hp infected mice was removed
at day 4 p.i. and carefully flattened between two glass slides for
imaging with an Olympus AX70 microscope (106objective). Movies
of granulomas, containing clearly visible larvae were recorded over a
time frame of 60 s (20 frames). Movies were processed using iMovie
software. Representative examples are shown.
(M4V)
Movie S2 FcRc and C3 dependent pathways contribute
to immune serum induced trapping of Hp larvae by
BMMac. Larvae were incubated with BMMac from C57BL/6 or
FcRc2/2 mice in the presence of immune serum from C57BL/6
or FcRc*C32/2 mice for 24 h. Suspensions from co-cultures were
transferred to glass slides, carefully covered with cover slips and
time lapse-movies were immediately recorded with an Olympus
AX70 microscope. Movies were processed using iMovie software.
Representative examples are shown.
(M4V)
Movie S3 Immune serum promotes adherence of
BMMac to L4 larvae in vitro. Larvae recovered from the
small intestine of challenge-infected mice were incubated with
BMMac in the presence of or absence of immune serum for 24 h.
Suspensions from co-cultures were transferred to glass slides,
carefully covered with cover slips and time lapse-movies were
immediately recorded with an Olympus AX70 microscope.
Movies were processed using iMovie software. Representative
examples are shown.
(M4V)
Movie S4 Arg1 deficiency impairs immune serum
induced trapping of larvae by BMMac in vitro. Larvae
were incubated with BMMac from Arg1f/fTie2-Cre or Tie2-Cre
mice in the presence of immune serum from challenge Hp infected
C57BL/6 mice for 24 h. Suspensions from co-cultures were
transferred to glass slides, carefully covered with cover slips and
time lapse-movies were immediately recorded with an Olympus
AX70 microscope. Movies were processed using iMovie software.
Representative examples are shown.
(M4V)
Movie S5 The arginase inhibitor BEC prevents larval
immobilization during challenge infection in vivo.
C57BL/6 mice were treated with S-(2-boronoethyl)-L-cysteine
(BEC) (0.2%, 100 ml by oral gavage) during challenge Hp infection.
Mice were sacrificed on day 4 p.i. and small intestines were
removed. Pieces of the upper duodenum were carefully covered
with cover slips and time lapse-movies were immediately recorded
with an Olympus AX70 microscope. Movies were processed using
iMovie software. Representative examples are shown.
(M4V)
Movie S6 L-ornithine and polyamines reduce larval
motility in vitro. Larvae were incubated in BMMac medium
supplemented with L-ornithine or polyamines (100 mM) for 24 h,
aliquots were transferred to glass slides and time lapse movies were
recorded immediately with an Olympus AX70 microscope.
Movies were processed using iMovie software. Representative
examples are shown.
(M4V)
Text S1 Supporting Materials and Methods and qPCR
primer sequences. Detailed descriptions of experimental
procedures, materials and data analysis methods including Fiji
macros and Cell profiler pipelines can be found in the Supporting
Information (Text S1).
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